COMMUNIQUÉS West-GlobeNewswire

-
RavenQuest Provides Corporate Update
26/06/2019 -
Change in the Terveystalo Plc Executive team: Johanna Karppi, SVP of HR to leave the company
26/06/2019 -
Zealand Pharma doses first subject in Phase 1 clinical trial with potential next generation dual-acting peptide therapeutic for short bowel syndrome
26/06/2019 -
Oasmia presents full-year report and status in the Board's review through audiocast on June 28
26/06/2019 -
DBV Technologies Announces Appointment of Pharis Mohideen, M.D., as Chief Medical Officer
26/06/2019 -
DBV Technologies annonce la nomination du Docteur Pharis Mohideen au poste de Directeur Médical
26/06/2019 -
Innate Pharma announces publication of IPH4102 Phase I clinical trial results for CTCL in the Lancet Oncology
26/06/2019 -
Innate Pharma annonce la publication des résultats de l’essai de Phase I d’IPH4102 dans les LTC dans The Lancet Oncology
26/06/2019 -
Helsinn appoints Giorgio Calderari, Group General Manager and Chief Operating Officer, to the Board of Directors
26/06/2019 -
Cambium Networks Corporation Announces Pricing of Initial Public Offering
26/06/2019 -
Wildflower Announces Closing of Private Placement
26/06/2019 -
ESPERITE (ESP) announces termination of negotiations regarding proposed sale of stem cell banking business to PBKM
25/06/2019 -
AIT Therapeutics Reports Financial Results for Fiscal Fourth Quarter and Year-End 2019 Results
25/06/2019 -
Medtronic Announces the Upsizing of its Maximum Tender Offer to up to $4.35 billion for Certain Outstanding Debt Securities Issued by Medtronic, Inc., Medtronic Global Holdings S.C.A. and Covidien International Finance S.A.
25/06/2019 -
Medtronic Announces Pricing of €5 Billion of Senior Notes
25/06/2019 -
Conformis Secures Up to $30 Million in Debt Financing and $3 Million in Equity Financing from Innovatus Life Sciences and East West Bank
25/06/2019 -
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
25/06/2019 -
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25/06/2019 -
Assembly Biosciences Announces Participation in the Microbiome Movement Drug Development Summit
25/06/2019
Pages